1. Home
  2. MRVI vs OTLY Comparison

MRVI vs OTLY Comparison

Compare MRVI & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • OTLY
  • Stock Information
  • Founded
  • MRVI 2014
  • OTLY 1994
  • Country
  • MRVI United States
  • OTLY Sweden
  • Employees
  • MRVI 560
  • OTLY N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • OTLY Packaged Foods
  • Sector
  • MRVI Health Care
  • OTLY Consumer Staples
  • Exchange
  • MRVI Nasdaq
  • OTLY Nasdaq
  • Market Cap
  • MRVI 350.1M
  • OTLY 303.5M
  • IPO Year
  • MRVI 2020
  • OTLY 2021
  • Fundamental
  • Price
  • MRVI $2.42
  • OTLY $17.59
  • Analyst Decision
  • MRVI Hold
  • OTLY Buy
  • Analyst Count
  • MRVI 10
  • OTLY 5
  • Target Price
  • MRVI $5.84
  • OTLY $19.25
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • OTLY 202.0K
  • Earning Date
  • MRVI 08-11-2025
  • OTLY 07-23-2025
  • Dividend Yield
  • MRVI N/A
  • OTLY N/A
  • EPS Growth
  • MRVI N/A
  • OTLY N/A
  • EPS
  • MRVI N/A
  • OTLY N/A
  • Revenue
  • MRVI $219,830,000.00
  • OTLY $828,200,000.00
  • Revenue This Year
  • MRVI N/A
  • OTLY $3.83
  • Revenue Next Year
  • MRVI $7.23
  • OTLY $4.51
  • P/E Ratio
  • MRVI N/A
  • OTLY N/A
  • Revenue Growth
  • MRVI N/A
  • OTLY 4.43
  • 52 Week Low
  • MRVI $1.67
  • OTLY $6.00
  • 52 Week High
  • MRVI $9.60
  • OTLY $20.80
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • OTLY 56.82
  • Support Level
  • MRVI $2.28
  • OTLY $17.75
  • Resistance Level
  • MRVI $2.47
  • OTLY $18.84
  • Average True Range (ATR)
  • MRVI 0.14
  • OTLY 0.93
  • MACD
  • MRVI -0.01
  • OTLY -0.06
  • Stochastic Oscillator
  • MRVI 27.45
  • OTLY 52.28

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

Share on Social Networks: